This content is machine translated How do weight loss interventions affect the muscles? Reflective evaluation: do not neglect qualitative aspects Both in the context of exclusively dietary interventions and after bariatric surgery or treatment with GLP(glucagon-like peptide)-1 analogs, there is not only a reduction in weight, but also a loss...…
View Post 6 min This content is machine translated Obesity in the family practice Aim for realistic goals and avoid apportioning blame Morbid obesity is a significant health risk factor and its prevalence has increased in many industrialized countries in recent years. The principles of weight reduction have hardly changed over the...…
View Post 2 min This content is machine translated "Swiss Health Care Atlas" New indicator: medication for weight regulation The healthcare atlas compiled under the auspices of Obsan documents and visualizes the frequency of medical treatments and diagnoses between cantons, regions, age groups and over time. This provides a...…
View Post 7 min This content is machine translated Longevity Medicine 2025 From anti-ageing to precision prevention Longevity Medicine in 2025 is less a marketing term than a clinical work program: moving away from fuzzy “anti-aging” promises towards measurable risk, biomarker and intervention logic. Drivers are a...…
View Post 5 min This content is machine translated Nutrition for type 2 diabetes Not such a great tuber The link between potato consumption and the risk of type 2 diabetes has long been debated. Although potatoes are a staple food worldwide, rich in starch and with a high...…
View Post 10 min This content is machine translated Mechanisms, evidence and therapeutic consequences GLP-1 receptor agonists in cardiology GLP-1 receptor agonists (GLP-1RAs) have rapidly evolved from antidiabetic drugs to cardiometabolic therapies with clinically proven reductions in hard cardiovascular endpoints – and increasingly beyond the traditional diabetes population. The...…
View Post 4 min This content is machine translated Early detection of type 1 diabetes Detection of insulin autoantibodies as an early marker Type 1 diabetes develops in several stages, whereby in the first preclinical phase only diabetes-specific autoantibodies are initially present in the blood, but the patients are normoglycaemic. Targeted screening is...…
View Post 3 min This content is machine translated Type 2 diabetes Smoking causes more than double the risk The characteristics of type 2 diabetes vary from patient to patient and the disease is thought to consist of four subtypes. However, a new study shows that smoking significantly increases...…
View Post 6 min This content is machine translated CKD: counteracting kidney progression and reducing the risk of CVD Targeted intervention through a multifactorial approach The Swiss Society of Nephrology (SGN) advocates targeted screening for defined risk groups. However, given the prevalence of chronic kidney disease (CKD) in primary care, it is hardly possible to...…
View Post 11 min This content is machine translated Alternative to insulin and GLP1 From the β-cell to the center: the versatile role of amylin Although amylin was discovered decades ago, its importance in everyday clinical practice has long been underestimated. New pharmacological developments are increasingly bringing amylin into the focus of diabetes and obesity...… CME-Test
View Post 6 min This content is machine translated Lipid management: ESC/EAS guideline update 2025 New recommendations on CVD risk classification, lipid lowering in statin intolerance and hoFH The European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) guideline update on the management of dyslipidemia continues to focus largely on how best to manage lipid levels to...…
